BACKGROUND: Left ventricular (LV) dyssynchrony by phase analysis has been studied by myocardial perfusion imaging (MPI)-gated SPECT in patients with LV dysfunction in various clinical settings. We aimed to investigate the routine use of phase analysis with gated SPECT for predicting cardiac outcome. METHODS: Patients referred to a tertiary medical center in 2010-2011 prospectively underwent a gated SPECT and phase analysis, and follow-up for cardiac events. The values of clinical variables, MPI, LV function, and LV dyssynchrony in predicting cardiac events were tested by univariate and multivariate analyses. RESULTS: The study group included 787 patients (66.5 ± 11 years, 81% men) followed for a mean duration of 18.3 ± 6.2 months. There were 45 (6%) cardiac events defined as composite endpoint; cardiac death occurred in 26 patients, and the rest had new-onset or worsening heart failure and life-threatening arrhythmias. In multivariate analysis, it was shown that NYHA class, diabetes mellitus, and LVEF <50% were the independent predictors for composite endpoint. However, the independent predictors for cardiac mortality were NYHA class (for each increment in class) and phase standard deviation (SD) (for each 10° increment). CONCLUSION: Gated SPECT with phase analysis for the assessment of LV dyssynchrony can successfully predict cardiac death together with NYHA class, in patients with LV dysfunction.
BACKGROUND:Left ventricular (LV) dyssynchrony by phase analysis has been studied by myocardial perfusion imaging (MPI)-gated SPECT in patients with LV dysfunction in various clinical settings. We aimed to investigate the routine use of phase analysis with gated SPECT for predicting cardiac outcome. METHODS:Patients referred to a tertiary medical center in 2010-2011 prospectively underwent a gated SPECT and phase analysis, and follow-up for cardiac events. The values of clinical variables, MPI, LV function, and LV dyssynchrony in predicting cardiac events were tested by univariate and multivariate analyses. RESULTS: The study group included 787 patients (66.5 ± 11 years, 81% men) followed for a mean duration of 18.3 ± 6.2 months. There were 45 (6%) cardiac events defined as composite endpoint; cardiac death occurred in 26 patients, and the rest had new-onset or worsening heart failure and life-threatening arrhythmias. In multivariate analysis, it was shown that NYHA class, diabetes mellitus, and LVEF <50% were the independent predictors for composite endpoint. However, the independent predictors for cardiac mortality were NYHA class (for each increment in class) and phase standard deviation (SD) (for each 10° increment). CONCLUSION: Gated SPECT with phase analysis for the assessment of LV dyssynchrony can successfully predict cardiac death together with NYHA class, in patients with LV dysfunction.
Authors: Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews Journal: N Engl J Med Date: 2002-03-19 Impact factor: 91.245
Authors: Aju P Pazhenkottil; Ronny R Buechel; Lars Husmann; René N Nkoulou; Mathias Wolfrum; Jelena-Rima Ghadri; Janine Kummer; Bernhard A Herzog; Philipp A Kaufmann Journal: Heart Date: 2010-10-20 Impact factor: 5.994
Authors: Zainab Samad; Allen E Atchley; Mark A Trimble; Jie-Lena Sun; Linda K Shaw; Robert Pagnanelli; Ji Chen; Ernest V Garcia; Ami E Iskandrian; Eric J Velazquez; Salvador Borges-Neto Journal: J Nucl Cardiol Date: 2010-11-17 Impact factor: 5.952
Authors: John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: John D Fisher; Alfred E Buxton; Kerry L Lee; Douglas L Packer; Debra S Echt; Pablo Denes; Michael H Lehmann; John P DiMarco; Denis Roy; Gail E Hafley Journal: Am J Cardiol Date: 2007-05-11 Impact factor: 2.778
Authors: Christophe Leclercq; Owen Faris; Richard Tunin; Jennifer Johnson; Ritsuchi Kato; Frank Evans; Julio Spinelli; Henry Halperin; Elliot McVeigh; David A Kass Journal: Circulation Date: 2002-10-01 Impact factor: 29.690
Authors: Mark A Trimble; Salvador Borges-Neto; Stuart Smallheiser; Ji Chen; Emily F Honeycutt; Linda K Shaw; Jaekyeong Heo; Robert A Pagnanelli; E Lindsey Tauxe; Ernest V Garcia; Fabio Esteves; Frank Seghatol-Eslami; G Neal Kay; Ami E Iskandrian Journal: J Nucl Cardiol Date: 2007-04-18 Impact factor: 5.952
Authors: Paul L Hess; Linda K Shaw; Sreekanth Vemulapalli; Robert Pagnanelli; Christopher M O'Connor; Salvador Borges-Neto Journal: J Nucl Cardiol Date: 2015-05-21 Impact factor: 5.952